-+ 0.00%
-+ 0.00%
-+ 0.00%

Mizuho Maintains Outperform on Tango Therapeutics, Raises Price Target to $40

Benzinga·07/17/2026 18:59:34
Listen to the news
Mizuho analyst Joseph Catanzaro maintains Tango Therapeutics (NASDAQ:TNGX) with a Outperform and raises the price target from $36 to $40.